H.E.B Allergy Relief Fexofenadine tablets recalled for impurity specification failure
Perrigo Company is recalling H.E.B Allergy Relief fexofenadine hydrochloride 60mg tablets nationwide due to failure of impurity specifications during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for a drug with no reported illnesses or injuries. The hazard involves impurity specification failure during stability testing, which is a manufacturing/quality issue rather than an acute safety event with documented harm. This fits the Moderate category for low-risk manufacturing defects.
Plain-English summary
Perrigo Company PLC is recalling H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg antihistamine in 12-count bottles nationwide in the USA. The recall affects NDC 37808-425-53 (UPC 0 41220 53080 9), manufactured in the Czech Republic for H.E.B in San Antonio, Texas.
The recall was initiated due to failed impurities and degradation specifications. During stability testing, an out-of-specification result was obtained for impurity A in affected lots.
The affected lots are: 0JE2491 with expiration date 01/31/2022, 0LE2178 with expiration date 01/31/2022, and 0ME2516 with expiration date 04/30/2022. A total of 26,304 containers were distributed.
Consumers who have purchased this product should stop use and consult their healthcare provider or pharmacist for guidance on alternative allergy relief options.
The recalled product
- Product
- H.E.B Allergy Relief, Fexofenadine Hydrochloride tablets, 12HR, 60mg/Antihistamine 12 count bottle, Made with Pride & Care for H.E.B. San Antonio TX 78204, Product of Czech Republic, NDC 37808-425-53, UPC 0 41220 53080 9
- Manufacturer
- Perrigo Company PLC
- Affected units
- 26,304
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot 0JE2491
- 0LE2178
- Exp 01/31/2022
- 0ME2516
- Exp 4/30/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity degradation
See all →- Low
- ModerateEsomeprazole Magnesium oral suspension recalled for failed impurity specifications
FDA (Drugs) · 2025-05-28
- HighDiltiazem Hydrochloride extended-release capsules recalled due to failed quality specifications
FDA (Drugs) · 2023-02-08
- ModerateXiidra ophthalmic solution recalled for failed impurity and degradation specifications
FDA (Drugs) · 2022-06-15
- ModerateXiidra Ophthalmic Solution Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2022-06-15